Every peptide question,answered.
ChatPEP is your AI assistant for peptide research. Answers grounded in 200M+ peer-reviewed papers, tailored to your goals.
Your expert peptide research assistant.
For the math, the morning after, and everything in between.
5mg vial, 2ml of water. How many units is 250mcg?
The number, the doses left in the vial, and the work shown.
Ask this
Week 3 on semaglutide. Is this nausea normal?
Yes, and it usually passes. The trial data explains why.
Ask this
Does BPC-157 actually do anything for tendons?
Here's what the studies found, sorted by how much weight they carry.
Ask this
PEP 3
The world's most advanced AI model for peptide research.
Your stack, tracked.
Add what you run, log each entry with one tap, and keep every vial counted. Free on every plan.
One tap logs it.
Add what you run and every entry lands on Today at its time. Tap the ring and it's logged with the dose, the next site in rotation, and the vial in use.
Every vial counted.
Each entry draws from the vial, so you always know about how many days and doses are left. Reminders come to your iPhone at the times you set.
The week at a glance.
One dot per day: filled when everything is logged, a ring when something is still open. No streaks, no scores. Just what you did.
Coming soon to iOS and Android.
Why not just ask a general AI?
Send the same question to both. The difference is what comes back.
A general assistant
I can't provide specific medical or dosing advice for BPC-157. It isn't FDA-approved for human use and is classified as a research chemical. Please consult a healthcare professional.
ChatPEP
The tendon evidence is strong, and it's preclinical. Rat models consistently report improved tendon and ligament healing, with better functional and biomechanical outcomes
The leading mechanism: BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts
Human evidence stays preliminary. What exists is small and uncontrolled, and no completed Phase II/III efficacy program supports clinical use today.
Are you asking for a specific injury?
It answers the question.
A question about a compound gets what the research says about it, in plain terms, and a follow-up when the picture is incomplete.
It shows the study.
Every claim carries a numbered source you can open, drawn from 200M+ peer-reviewed papers.
It knows your stack.
Answers take into account what you run, your medications, and your goals, and warn you about interactions first.
Say it once.
Mention a condition, a medication, or a goal one time, and ChatPEP carries it into every conversation after. You never explain yourself twice.
Tuesday
The next week
Since you're on levothyroxine, here's how the research approaches that combination first…
On every plan, from your first message.
Try it freeResearch that comes to you.
Pulse keeps watch between conversations and checks in at the moments that matter: week six of a course, a dose change, new research on a compound you run.
Your GHK-Cu course is wrapping up
nowYou're at week 6. Here's what the research says about course length, and what's worth reassessing before you decide on the next one.
You moved up a dose this week
nowNausea clusters around each escalation in the trials. Here's what they report about the first week at a new step.
Pulse follows up on Frontier.
See plansCheck your math.
Vial, water, dose. ChatPEP runs the numbers and shows the work, so the one mistake that matters gets caught on screen.
- Concentration
- 25 mcg per unit
- Doses per vial
- 20
250 mcg = 10 units · 0.1 ml
This information is for research only. Not intended for human use.
Signed in, the numbers travel with the question, and every figure you state gets checked against the math before ChatPEP answers.
Designed to keep you safe.
Every question is checked against your biometrics, because the interaction that matters is the one you'd never think to ask about.
Interaction Warning
Semaglutide + Insulin
Adding semaglutide to insulin raises hypoglycemia risk, and case-control data identify insulin co-use as the principal hypoglycemia risk factor.
Recent news
Model releases, new research, and what changed in the knowledge base.
Studies5 min read
Stroke data tie Cerebrolysin to better cognition after prior decline
A new analysis of the C-REGS2 stroke study found that Cerebrolysin was linked to better 90-day cognition, with the largest gains in people who had cognitive decline before their stroke.
Guide6 min read
How to tell a rat study from a human trial
Most headlines about a peptide hide the species behind the finding. Learn to spot whether a claim rests on a rat study or a human trial, and what each level of evidence can and cannot tell you.
Studies4 min read
What the studies show about CJC-1295 in 2026
One injection of CJC-1295 kept growth hormone and IGF-1 elevated for days in controlled trials, but no human study has connected that to muscle, recovery, or body-composition benefit.
Don't take peptides blindly.
Going in without answers is guessing with your health. ChatPEP grounds every answer in the research and weighs it against your biometrics.
Ask before you start